Pain Medicine News

  • Home
  • Pain Medicine News

Pain Medicine News A publication for the clinician interested in the diagnosis, treatment and management of pain.

Pain Medicine News, the most widely read pain publication in the United States according to Kantar Media, is mailed to 41,828 pain-treating physicians and to 41,152 pain-treating nurse practitioners and physician assistants. It offers extensive coverage of major scientific meetings affecting the specialty, feature articles on topics relevant to practicing provider, in-depth clinical reviews, pract

ice management articles, medical education, as well as a full line of digital media, including the PainMedicineNews.com website, e-Newsletters, and multimedia content.

LAS VEGAS—Surgeon and physician perceptions of patients’ postoperative pain suggest that inadequately managed pain negat...
13/02/2025

LAS VEGAS—Surgeon and physician perceptions of patients’ postoperative pain suggest that inadequately managed pain negatively affects patient recovery and reflects a need for more effective, safer therapeutics, according to the findings of a recent stu

https://www.painmedicinenews.com/a/gikBAA/f

Eric Jones, MD, discusses a case involving use of a stellate ganglion block for refractory migraine in the debut install...
12/02/2025

Eric Jones, MD, discusses a case involving use of a stellate ganglion block for refractory migraine in the debut installment of “Fellowship of Pain,” a new video series from Pain Medicine News that highlights the important work of residents.

https://www.painmedicinenews.com/a/rykBAA/f

Safer pharmaceutical-grade alternatives to toxic and unregulated supplies of opioids could help address opioid diversion...
11/02/2025

Safer pharmaceutical-grade alternatives to toxic and unregulated supplies of opioids could help address opioid diversion issues for patients to better prevent overdoses and other harms linked to the toxic drug supply.

https://www.painmedicinenews.com/a/fCkBAA/f

Patients referred for medical cannabis use to treat anxiety disorders or severe chronic or intractable pain reported “ra...
10/02/2025

Patients referred for medical cannabis use to treat anxiety disorders or severe chronic or intractable pain reported “rapid and significant improvements” in health-related quality of life after three months.

https://www.painmedicinenews.com/a/hikBAA/f

The FDA has approved a combination of meloxicam and rizatriptan (Symbravo, Axsome Therapeutics) for the acute treatment ...
10/02/2025

The FDA has approved a combination of meloxicam and rizatriptan (Symbravo, Axsome Therapeutics) for the acute treatment of migraine with or without aura in adults.

https://www.painmedicinenews.com/a/qSkBAA/f

A multimodal analgesia-based enhanced recovery after surgery protocol following cardiac surgery not only reduces intraop...
07/02/2025

A multimodal analgesia-based enhanced recovery after surgery protocol following cardiac surgery not only reduces intraoperative opioid administration, but also decreases postoperative opioid prescriptions, a finding authors said may have far-reaching e

https://www.painmedicinenews.com/a/oSkBAA/f

Peripheral nerve stimulation first emerged more than 50 years ago, but it fell out of favor for some time because of sub...
07/02/2025

Peripheral nerve stimulation first emerged more than 50 years ago, but it fell out of favor for some time because of suboptimal clinical outcomes, poor long-term success rates, and complications such as nerve damage and stimulation-induced fibrosis.

https://www.painmedicinenews.com/a/eSkBAA/f

05/02/2025

The FDA has approved Avtozma (CT-P47, tocilizumab-anoh, Celltrion) as both an intravenous and subcutaneous (SC) formulation as a biosimilar to Actemra for the treatment of multiple disease

https://www.painmedicinenews.com/a/YykBAA/f

Investigators have begun studying the role that endocannabinoids play in addressing opioid addiction by testing the biol...
05/02/2025

Investigators have begun studying the role that endocannabinoids play in addressing opioid addiction by testing the biological impact of increasing endocannabinoids on opioid reward behavior.

https://www.painmedicinenews.com/a/ZSkBAA/f

04/02/2025

The FDA has approved EVA (Saluda), a biomarker-based, automated patient programming platform in SCS, compatible with all commercially implanted Evoke System patients in the United States.

https://www.painmedicinenews.com/a/YSkBAA/f

A combination of common over-the-counter painkillers is more effective in reducing pain than opioids for patients underg...
03/02/2025

A combination of common over-the-counter painkillers is more effective in reducing pain than opioids for patients undergoing wisdom teeth removal, a new study found.

https://www.painmedicinenews.com/a/YikBAA/f

31/01/2025

The FDA has approved suzetrigine (Journavx, Vertex Pharmaceuticals) 50 mg oral tablets as a first-in-class nonopioid analgesic to treat all types of moderate-to-severe acute pain in adults.

https://www.painmedicinenews.com/a/VykBAA/f

Researchers found that there was a need to systematically assess the reliability, validity and responsiveness of the pe...
29/01/2025

Researchers found that there was a need to systematically assess the reliability, validity and responsiveness of the performance-based tests used in patients with fibromyalgia.

https://www.painmedicinenews.com/a/HSkBAA/f

28/01/2025

A newly discovered pain receptor for nerve growth factor could pave the way for new drug development for conditions like arthritis, inflammatory pain and cancer pain—potentially without the additional side effects of current treatments.

https://www.painmedicinenews.com/a/GykBAA/f

Address


Website

Alerts

Be the first to know and let us send you an email when Pain Medicine News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Pain Medicine News:

Shortcuts

  • Address
  • Alerts
  • Contact The Business
  • Claim ownership or report listing

  • Want your business to be the top-listed Media Company?

Share